For most patients, gastrointestinal side effects are mild to moderate and tend to improve as the body adjusts to the medication
More on, ADA and AACE Guidelines prefer GLP1RA over DPP4i for patients with established ASCVD or indicators of high ASCVD risk, CKD 3, or heart failure 1
They throw formulas at you without context
Among them, GLP-1 and GIP (gastric inhibitory polypeptide) are known as incretins, gut-derived hormones that enhance glucose-dependent insulin secretion, playing a pivotal role in maintaining glucose homeostasis and serve as important therapeutic targets for type 2 diabetes and obesity
Additionally, sustained engagement in physical activity after treatment cessation appears more likely when exercise is integrated alongside pharmacotherapy, while GLP-1 therapies alone may be associated with lower post-treatment activity levels
If you are exercising consistently, muscle glycogen stores may be replenishing, which adds water weight